Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Valencia NutritionBOM:542910 51 Days Payable is 90.04 as of Mar. 2026, which is 21% above its 10-year median of 74.33. GuruFocus rates BOM:542910 with a GF Score™ of 51/100 and a GF Value™ of ₹65.92 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 703 Biotechnology companies, Valencia Nutrition ranks worse than 56.19% on this metric.
The historical rank and industry rank for Valencia Nutrition's Days Payable or its related term are showing as below:
BOM:542910'
s Days Payable Range Over the Past 10 Years
Min: 15.25 Med: 74.33 Max: 10838.55
Current: 82.28
During the past 10 years, Valencia Nutrition's highest Days Payable was 10838.55. The lowest was 15.25. And the median was 74.33.
BOM:542910's Days Payable is ranked worse than 56.19% of 703
companies
in the Biotechnology industry
Industry Median: 112.61
vs BOM:542910: 82.28
Valencia Nutrition's Days Payable
increased
from Mar. 2025 (8.06) to Mar. 2026 (90.04).
It may suggest that Valencia Nutritiondelayed paying its suppliers.
The historical data trend for Valencia Nutrition's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:542910 vs VRTX, REGN, RVMD: Days Payable Comparison
For the Biotechnology subindustry, Valencia Nutrition's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Valencia Nutrition Days Payable vs Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Valencia Nutrition's Days Payable distribution charts can be found below:
* The bar in red indicates where Valencia Nutrition's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Valencia Nutrition's Days Payable for the fiscal year that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Valencia Nutrition (BOM:542910) has a Days Payable of 90.04 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Valencia Nutrition and its competitors. This is 21% above median its historical median of 74.33. Over the past decade, Valencia Nutrition's Days Payable has ranged from 15.25 to 10,838.55. According to the industry distribution chart, Valencia Nutrition ranks #395 out of 703 companies in the Biotechnology industry, placing it in the top 56.2%.
Is Valencia Nutrition's Days Payable too high?
Valencia Nutrition's current Days Payable of 90.04 is 21% above median its 10-year median of 74.33. Over the past 10 years, this metric has ranged from a low of 15.25 to a high of 10,838.55. The Biotechnology industry median Days Payable is 112.61. Valencia Nutrition's value of 90.04 is 20% below this industry median. Based on the distribution chart, Valencia Nutrition ranks #395 out of 703 companies in the Biotechnology industry, which is below the industry midpoint. Overall, Valencia Nutrition has a GF Score™ of 51/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Valencia Nutrition's Days Payable compare to VRTX and REGN?
According to the Biotechnology industry distribution chart, Valencia Nutrition ranks #395 out of 703 companies for Days Payable. This places Valencia Nutrition in the lower half of its industry. The industry median Days Payable is 112.61. Valencia Nutrition's value of 90.04 is 20% below this benchmark. Historically, Valencia Nutrition's own Days Payable has ranged from 15.25 to 10,838.55 over the past decade. While the company's 10-year median is 74.33 vs. the industry median of 112.61, Valencia Nutrition has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Biotechnology company?
The median Days Payable among Biotechnology companies is 112.61, based on 703 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Valencia Nutrition's current Days Payable of 90.04 is 20% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Valencia Nutrition and its competitors. For the Biotechnology industry, the median Days Payable is 112.61 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Valencia Nutrition's current Days Payable is 90.04, which is 21% above median its own 10-year median of 74.33. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Valencia Nutrition stock overvalued right now?
Based on GuruFocus' analysis, Valencia Nutrition (BOM:542910) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹65.92, compared to a current price of ₹49.80 — trading 24.5% below its estimated fair value. The current Days Payable is 90.04, which is 21% above median its 10-year median of 74.33 and 20% below the Biotechnology industry median of 112.61. Valencia Nutrition's overall GF Score™ is 51/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Valencia Nutrition (BOM:542910), the current Days Payable is 90.04 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Valencia Nutrition (BOM:542910) Overvalued in 2026?
Based on GuruFocus' analysis, Valencia Nutrition stock appears to be undervalued.
The current stock price of ₹49.80 is trading 24.5% below its estimated GF Value™ of ₹65.92.
GuruFocus considers Valencia Nutrition to be Modestly Undervalued.
Key valuation signals for BOM:542910:
Days Payable: 90.04 (21% above median its 10-year median of 74.33)
GF Value™: ₹65.92 vs. price of ₹49.80 (24.5% below fair value)
Industry Position: 20% below the Biotechnology median (#395 of 703)
No single metric tells the full story. See the BOM:542910 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Valencia Nutrition Ltd is a biotechnology company engaged in researching, developing, manufacturing, selling, and distributing nutraceutical products such as multi-nutrient functional beverages to prevent and/or manage lifestyle-related diseases. The company's products include Bounce Superdrinks and VitaMe Enriched Beverages.
51GF Score
Get the complete analysis for BOM:542910
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:542910 has been successfully added to your 
